Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · IEX Real-Time Price · USD
30.00
-0.60 (-1.96%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Dianthus Therapeutics Market Cap

Dianthus Therapeutics has a market cap or net worth of $524.21 million as of March 28, 2024. Its market cap has increased by 1,054.65% in one year.

Market Cap
524.21M
Enterprise Value
351.08M
1-Year Change
1,054.65%
Ranking
Category
Stock Price
$30.00

Market Cap Chart

Since June 21, 2018, Dianthus Therapeutics's market cap has increased from $499.10M to $524.21M, an increase of 5.03%. That is a compound annual growth rate of 0.85%.

History

DateMarket Cap% Change
Mar 28, 2024880.40M-1.96%
Mar 27, 2024898.00M-2.92%
Mar 26, 2024925.00M1.70%
Mar 25, 2024909.50M-2.97%
Mar 22, 2024937.30M14.32%
Mar 21, 2024819.90M104.16%
Mar 20, 2024401.60M2.50%
Mar 19, 2024391.80M0.36%
Mar 18, 2024390.40M-6.06%
Mar 15, 2024415.60M4.37%
Mar 14, 2024398.20M-8.29%
Mar 13, 2024434.20M16.50%
Mar 12, 2024372.70M0.30%
Mar 11, 2024371.60M-0.21%
Mar 8, 2024372.40M-0.75%
Mar 7, 2024375.20M1.32%
Mar 6, 2024370.30M0.84%
Mar 5, 2024367.20M-2.68%
Mar 4, 2024377.30M-1.13%
Mar 1, 2024381.60M4.06%
Feb 29, 2024366.70M2.69%
Feb 28, 2024357.10M-5.50%
Feb 27, 2024377.90M0.08%
Feb 26, 2024377.60M4.28%
Feb 23, 2024362.10M1.83%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
COMPASS Pathways 534.37M
Biomea Fusion 533.80M
Phibro Animal Health 528.98M
Nevro 528.41M
Cibus 525.35M
P3 Health Partners 521.75M
Revance Therapeutics 514.83M
UroGen Pharma 511.83M
Market Cap Rankings